Stock Scorecard
Stock Summary for Globus Medical Inc - Class A (GMED) - $96.71 as of 2/27/2026 3:10:01 PM EST
Total Score
12 out of 30
Safety Score
49 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for GMED
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for GMED
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for GMED
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for GMED
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for GMED (49 out of 100)
| Stock Price Rating (Max of 10) | 9 |
| Historical Stock Price Rating (Max of 10) | 9 |
| Stock Price Trend (Max of 10) | 9 |
| Book Value (Max of 10) | 8 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 5 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 5 |
| Trading Volume (Max of 10) | 9 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | -10 |
Latest News for for GMED
Financial Details for GMED
Company Overview |
|
|---|---|
| Ticker | GMED |
| Company Name | Globus Medical Inc - Class A |
| Country | N/A |
| Description | Globus Medical, Inc., a medical device company, develops and markets healthcare solutions for patients with musculoskeletal disorders. The company is headquartered in Audubon, Pennsylvania. |
| Sector Name | HEALTHCARE |
| Industry Name | MEDICAL DEVICES |
| Most Recent Quarter | 9/30/2025 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 96.71 |
| Price 4 Years Ago | 74.27 |
| Last Day Price Updated | 2/27/2026 3:10:01 PM EST |
| Last Day Volume | 1,179,805 |
| Average Daily Volume | 1,235,237 |
| 52-Week High | 101.40 |
| 52-Week Low | 51.79 |
| Last Price to 52 Week Low | 86.73% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 45.58 |
| Sector PE | 46.86 |
| 5-Year Average PE | 28.46 |
| Free Cash Flow Ratio | 20.49 |
| Industry Free Cash Flow Ratio | 26.39 |
| Sector Free Cash Flow Ratio | 25.71 |
| Current Ratio Most Recent Quarter | 4.26 |
| Total Cash Per Share | 4.72 |
| Book Value Per Share Most Recent Quarter | 32.68 |
| Price to Book Ratio | 1.83 |
| Industry Price to Book Ratio | 4.96 |
| Sector Price to Book Ratio | 52.77 |
| Price to Sales Ratio Twelve Trailing Months | 4.42 |
| Industry Price to Sales Ratio Twelve Trailing Months | 4.39 |
| Sector Price to Sales Ratio Twelve Trailing Months | 22.39 |
| Analyst Buy Ratings | 6 |
| Analyst Strong Buy Ratings | 5 |
Share Statistics |
|
| Total Shares Outstanding | 111,409,000 |
| Market Capitalization | 10,774,364,390 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 131.60% |
| Annual Earnings Growth | 422.31% |
| Reported EPS 12 Trailing Months | 3.09 |
| Reported EPS Past Year | 4.00 |
| Reported EPS Prior Year | 3.14 |
| Net Income Twelve Trailing Months | 537,900,000 |
| Net Income Past Year | 537,900,000 |
| Net Income Prior Year | 102,984,000 |
| Quarterly Revenue Growth YOY | 22.90% |
| 5-Year Revenue Growth | 30.08% |
| Operating Margin Twelve Trailing Months | 22.20% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 526,156,000 |
| Total Cash Past Year | 526,156,000 |
| Total Cash Prior Year | 784,438,000 |
| Net Cash Position Most Recent Quarter | 89,014,000 |
| Net Cash Position Past Year | 108,756,000 |
| Long Term Debt Past Year | 417,400,000 |
| Long Term Debt Prior Year | 417,400,000 |
| Total Debt Most Recent Quarter | 437,142,000 |
| Equity to Debt Ratio Past Year | 0.92 |
| Equity to Debt Ratio Most Recent Quarter | 0.91 |
| Total Stockholder Equity Past Year | 4,573,250,000 |
| Total Stockholder Equity Prior Year | 4,177,333,000 |
| Total Stockholder Equity Most Recent Quarter | 4,573,250,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 578,768,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 5.19 |
| Free Cash Flow Past Year | 588,768,000 |
| Free Cash Flow Prior Year | 405,209,000 |
Options |
|
| Put/Call Ratio | 0.16 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.79 |
| MACD Signal | 0.03 |
| 20-Day Bollinger Lower Band | 63.66 |
| 20-Day Bollinger Middle Band | 85.13 |
| 20-Day Bollinger Upper Band | 106.59 |
| Beta | 1.06 |
| RSI | 66.08 |
| 50-Day SMA | 0.00 |
| 150-Day SMA | 65.66 |
| 200-Day SMA | 65.14 |
System |
|
| Modified | 2/28/2026 12:32:09 AM EST |